Chromogranin A Expression in Patients With Hormone Naïve Prostate Cancer Predicts the Development of Hormone Refractory Disease-Reference-Cited by-同舟云学术

Chromogranin A Expression in Patients With Hormone Naïve Prostate Cancer Predicts the Development of Hormone Refractory Disease

Published:2007-09 Issue:3 Volume:178 Page:838-843
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Berruti Alfredo¹,Mosca Alessandra¹,Porpiglia Francesco²,Bollito Enrico³,Tucci Marcello¹,Vana Federica¹,Cracco Cecilia²,Torta Mirella¹,Russo Lucianna¹,Cappia Susanna³,Saini Andrea¹,Angeli Alberto⁴,Papotti Mauro³,Scarpa Roberto Mario²,Dogliotti Luigi¹

Affiliation:

1. Division of Medical Oncology, Department of Clinical & Biological Sciences, University of Turin and San Luigi Hospital, Orbassano, Torino, Italy

2. Division of Urology, Department of Clinical & Biological Sciences, University of Turin and San Luigi Hospital, Orbassano, Torino, Italy

3. Division of Pathology, Department of Clinical & Biological Sciences, University of Turin and San Luigi Hospital, Orbassano, Torino, Italy

4. Division of Internal Medicine, Department of Clinical & Biological Sciences, University of Turin and San Luigi Hospital, Orbassano, Torino, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. National Comprehensive Cancer Network guidelines for the management of prostate cancer;Scherr;Urology,2003

2. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer;Kattan;J Natl Cancer Inst,1998

3. Neuroendocrine cells in tumour growth of the prostate;Abrahamsson;Endocr Relat Cancer,1999

4. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease;Berruti;Endocr Relat Cancer,2005

5. Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study;Taplin;Urology,2005

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in prostate cancer treatment: Radionuclide therapy for prostate cancer;Advances in Cancer Research;2024

2. Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration‐resistant prostate cancer;The Prostate;2023-03-16

3. Synaptophysin and chromogranin A expression analysis in human tumors;Molecular and Cellular Endocrinology;2022-09

4. Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation;Frontiers in Oncology;2022-07-22

5. BRCA2 Alterations in Neuroendocrine/Small-Cell Carcinoma Prostate Cancer: A Case Series;JCO Precision Oncology;2022-07